FdaApplication

ANDA 208543

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINVAGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2025-05-14

Products (3)

ProductActive ingredientStrengthDosage form
RIVAROXABANRIVAROXABAN20MGTABLET;ORAL
RIVAROXABANRIVAROXABAN15MGTABLET;ORAL
RIVAROXABANRIVAROXABAN10MGTABLET;ORAL

3 products